Company Recordati

Equities

REC

IT0003828271

Pharmaceuticals

Market Closed - Borsa Italiana 11:44:59 2024-04-25 am EDT 5-day change 1st Jan Change
48.8 EUR -2.36% Intraday chart for Recordati -1.89% -0.06%

Business Summary

Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;

- medicines for rare diseases (32.1%).

Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).

Number of employees: 4,455

Sales per Business

EUR in Million2022Weight2023Weight Delta
Specialty & Primary Care
65.7 %
1,258 67.9 % 1,368 65.7 % +8.75%
Rare Diseases
34.3 %
596 32.1 % 715 34.3 % +19.96%

Sales per region

EUR in Million2022Weight2023Weight Delta
Europe
56.4 %
1,084 58.5 % 1,175 56.4 % +8.37%
America
19.0 %
324 17.5 % 395 19.0 % +22.06%
Italy
15.2 %
277 15.0 % 317 15.2 % +14.36%
Australasia
6.7 %
115 6.2 % 140 6.7 % +21.69%
Africa
2.7 %
53 2.9 % 56 2.7 % +3.96%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 21-11-30
Director of Finance/CFO 54 19-10-31
Chairman 52 98-04-28
Chief Tech/Sci/R&D Officer - 17-06-30
Director/Board Member 71 20-04-28
Investor Relations Contact 51 20-09-30
General Counsel - 23-03-31
General Counsel - 23-03-31
Human Resources Officer - 22-12-31
Corporate Officer/Principal - 07-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 50 18-06-11
Director/Board Member 54 18-06-11
Chief Executive Officer 61 21-11-30
Director/Board Member 51 22-04-28
Director/Board Member 56 20-04-28
Director of Finance/CFO 54 19-10-31
Director/Board Member 62 21-12-15
Director/Board Member 53 14-04-16
Director/Board Member 71 20-04-28
Director/Board Member 60 19-02-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 209,125,156 97,110,939 ( 46.44 %) 3,119,044 ( 1.491 %) 46.44 %

Shareholders

NameEquities%Valuation
CVC Advisers Ltd.
51.82 %
108,368,721 51.82 % 5 997 M €
Invesco Asset Management Ltd.
2.278 %
4,763,870 2.278 % 264 M €
RECORDATI
1.801 %
3,765,552 1.801 % 208 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.6352 %
1,328,419 0.6352 % 74 M €
Invesco Advisers, Inc.
0.5980 %
1,250,568 0.5980 % 69 M €
ANIMA Sgr SpA
0.5619 %
1,175,080 0.5619 % 65 M €
DWS Investments Italy SGR SpA
0.4225 %
883,639 0.4225 % 49 M €
Capitalia Asset Management SGR SpA
0.4065 %
850,000 0.4065 % 47 M €
Eurizon Capital SGR SpA
0.3329 %
696,252 0.3329 % 39 M €
Banque Degroof Petercam SA (Private Banking)
0.3323 %
695,000 0.3323 % 38 M €
NameEquities%Valuation
First Horizon Advisors, Inc.
0.000017 %
140 0.000017 % 1 934 €

Holdings

NameEquities%Valuation
3,765,552 1.80% 208,382,635 $
9,554,140 3.54% 26,854,108 $
43,103 0.71% 138,723 $

Company contact information

Recordati SpA

Via Matteo Civitali, 1

20148, Milan

+39 02 487871

http://www.recordati.it/
address Recordati(REC)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Drugstore Chains
Recordati Ilac San ve Tic AS
Household/Personal Care
Medical Distributors

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.8 EUR
Average target price
52.14 EUR
Spread / Average Target
+6.84%
Consensus